Jiangsu Hengrui Pharmaceuticals Co.,Ltd (HKG:1276)

Market Cap	462.87B
Revenue (ttm)	33.86B
Net Income (ttm)	8.16B
Shares Out	n/a
EPS (ttm)	1.27
PE Ratio	56.71
Forward PE	43.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,582,125
Average Volume	3,551,909
Open	74.20
Previous Close	74.70
Day's Range	72.45 - 74.90
52-Week Range	52.50 - 95.20
Beta	n/a
RSI	53.68
Earnings Date	Apr 21, 2026

About HKG:1276

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1970
• Employees: 20,238
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1276

Financial Performance

In 2024, HKG:1276's revenue was 27.98 billion, an increase of 22.63% compared to the previous year's 22.82 billion. Earnings were 6.34 billion, an increase of 47.28%.

Financial numbers in CNY